Coherus Oncology CHRS
NASDAQ CHRS
$0.75 +0.00 (+0.56%)
As of: Nov 6, 2026 · 9:54 AM EST

Coherus Oncology (CHRS) Net Long-Term Debt Issued (Repaid) (2016 - 2024)

Updated

Coherus Oncology's Non-Current Debt came in at $37.25 million for Q2 2026, up 1.0% from $36.87 million a year earlier and up 0.3% from the prior quarter.

Analysis

Coherus Oncology (CHRS) Net Long-Term Debt Issued (Repaid) (2016 - 2024) Analysis & Trends

At the end of FY2025, Coherus Oncology's Non-Current Debt was $37.05 million, up 1.0% from FY2024.

  • Non-Current Debt carries a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
  • Going back by year, Non-Current Debt was $36.7 million in FY2024 (-85.1%), $246.48 million in FY2023 (+0.4%), $245.48 million in FY2022 (+225.1%) and $75.51 million in FY2021 (+1.4%).
  • The Q2 2026 figure represents the highest quarterly Non-Current Debt since Q1 2024.
  • Year-over-year, Non-Current Debt has increased for five consecutive quarters, with an average decline of 26.8% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Debt over five years came in Q3 2022 (growth of 323.4%), and the weakest in Q2 2024 (a decline of 85.1%).
  • Business Quant data shows CHRS's Non-Current Debt at $37.15 million (Q1 2026), $37.05 million (Q4 2025) and $36.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,221.54 Bn 1,195.15 Bn 20.46 Bn -
2 Johnson & Johnson 650.21 Bn 570.07 Bn 17.30 Bn -1.00 Mn
3 AbbVie 508.24 Bn 476.24 Bn 13.12 Bn 9.98 Bn
4 Merck 360.07 Bn 323.01 Bn 13.19 Bn -
5 Novartis Ag 312.26 Bn 285.49 Bn - -
6 Astrazeneca 285.31 Bn 259.20 Bn 13.26 Bn 4.91 Bn
7 Amgen 247.74 Bn 199.39 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 207.12 Bn 182.22 Bn 6.73 Bn -19.00 Mn
9 Pfizer 166.13 Bn 113.48 Bn 12.56 Bn -
10 Coherus Oncology 116.17 Mn -519.97 Mn 10.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -141,000.00
Dec 31, 2022 81.75 Mn
Sep 30, 2022 49.49 Mn
Mar 31, 2022 440,000.00
Mar 31, 2021 222.20 Mn
Sep 30, 2020 -674,000.00
Jun 30, 2020 222.83 Mn
Sep 30, 2019 -106,000.00
Jun 30, 2019 185,000.00
Mar 31, 2019 72.88 Mn
Mar 31, 2016 100.00 Mn
API Access

Coherus Oncology Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEY